Halozyme Therapeutics Inc (HALO) — Working Capital to Net Assets Ratio
Halozyme Therapeutics Inc (HALO) has a Working Capital to Net Assets ratio of 97.5% as of September 2025. Working capital of $491.52 Million (current assets of $1.33 Billion minus current liabilities of $837.23 Million) is measured against net assets of $503.92 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See HALO days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Halozyme Therapeutics Inc Working Capital to Net Assets (2001–2024)
This chart shows how Halozyme Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 24 annual periods from 2001 to 2024. As of September 2025, the ratio stands at 97.5%, reflecting working capital of $491.52 Million against net assets of $503.92 Million USD. For the complete balance sheet picture, see how large is Halozyme Therapeutics Inc's balance sheet.
Annual Working Capital to Net Assets for Halozyme Therapeutics Inc (2001–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Halozyme Therapeutics Inc from 2001 to 2024, covering 24 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Halozyme Therapeutics Inc liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 260.1% | $946.24 Million | $363.82 Million | $1.09 Billion | $139.10 Million | ▼ -496.3 pp |
| 2023 | 756.4% | $633.93 Million | $83.81 Million | $746.42 Million | $112.49 Million | ▲ +398.2 pp |
| 2022 | 358.2% | $608.22 Million | $169.80 Million | $739.01 Million | $130.79 Million | ▼ -52.6 pp |
| 2021 | 410.8% | $809.14 Million | $196.95 Million | $926.29 Million | $117.15 Million | ▲ +322.5 pp |
| 2020 | 88.3% | $133.38 Million | $151.05 Million | $554.76 Million | $421.38 Million | ▼ -410.6 pp |
| 2019 | 498.9% | $457.80 Million | $91.77 Million | $543.44 Million | $85.64 Million | ▲ +387.0 pp |
| 2018 | 111.9% | $278.49 Million | $248.89 Million | $427.85 Million | $149.36 Million | ▼ -70.0 pp |
| 2017 | 181.9% | $379.04 Million | $208.37 Million | $510.37 Million | $131.33 Million | ▲ +803.7 pp |
| 2016 | -621.7% | $201.95 Million | $-32.48 Million | $256.53 Million | $54.59 Million | ▼ -876.0 pp |
| 2015 | 254.2% | $109.31 Million | $43.00 Million | $171.77 Million | $62.46 Million | ▼ -77.1 pp |
| 2014 | 331.3% | $136.99 Million | $41.35 Million | $161.32 Million | $24.33 Million | ▲ +680.2 pp |
| 2013 | -348.9% | $69.74 Million | $-19.99 Million | $95.20 Million | $25.45 Million | ▼ -578.3 pp |
| 2012 | 229.4% | $112.08 Million | $48.85 Million | $131.03 Million | $18.95 Million | ▼ -198.9 pp |
| 2011 | 428.3% | $46.69 Million | $10.90 Million | $63.99 Million | $17.30 Million | ▲ +63.9 pp |
| 2010 | 364.4% | $74.16 Million | $20.35 Million | $89.50 Million | $15.34 Million | ▼ -505.4 pp |
| 2009 | 869.8% | $60.04 Million | $6.90 Million | $74.44 Million | $14.40 Million | ▲ +481.0 pp |
| 2008 | 388.8% | $59.79 Million | $15.38 Million | $74.01 Million | $14.22 Million | ▲ +229.0 pp |
| 2007 | 159.8% | $92.31 Million | $57.77 Million | $101.18 Million | $8.86 Million | ▼ -19.3 pp |
| 2006 | 179.1% | $41.34 Million | $23.08 Million | $45.59 Million | $4.25 Million | ▲ +81.3 pp |
| 2005 | 97.8% | $17.80 Million | $18.21 Million | $20.11 Million | $2.30 Million | ▼ -0.5 pp |
| 2004 | 98.3% | $14.57 Million | $14.82 Million | $16.15 Million | $1.58 Million | ▼ -1.7 pp |
| 2003 | 100.0% | $10.06K | $10.06K | $47.52K | $37.45K | ▲ +0.0 pp |
| 2002 | 100.0% | $86.81K | $86.81K | $97.25K | $10.43K | ▲ +0.0 pp |
| 2001 | 100.0% | $22.84K | $22.84K | $26.13K | $3.29K | — |